Tedco awards $600K to tech firms - Phoenix Business Journal:

shelly-polymer.blogspot.com
The money was granted in collaboration withthe U.S. Army Medicall Research and Materiel Command and the throughthe Ft. Detrick Technologty Transfer Initiative. The purpose of the technologyu transfer program is to raise awareness of new and developinvg technologies and funding them to transitiom as viable projectsfor follow-o funding in the market place. Each companyy that received funding was awardedapproximatelyy $50,000 between March 2008 and May 2009, makinv up the initiative’s second round of financialo awards since its $750,000 program extension. The fundsw for the program’s second phase were securex by Sen. Barbara Mikulski, D-Md., and Rep. Roscoes G. Bartlett, R-Md.
“The [Ft. Detrick Technologyt Transfer Initiative] program is enabling area businessed to harness the technologies being developed at Fort Detrico and apply them to thecommercia sector,” said Mikulski. “This will lead to new products that have the power to create jobs and save Mikulski announced the first phase of the tech transfed program in March 2005 when 11 companies received in Rockville: The company is developing a health care technologyh called miTag system, which is a scalables wireless sensor solution for improving patientf flow. in Frederick: The company is developin a technology called the GeNova Screento isolate, and produce antibody-like molecules.
in The company is developing an on-demand biotech productxs including a combination vaccine against plague and BioAssay Works LLCin Ijamsville: The companu is developing a lateral-flow visual diagnosticd test to detect and differentiate single sample multiple pathogenivc poxviruses, including variola, vaccinia, and monkeypox. in Catonsville: The companyt is safety-testing a medical producft called ClotFoam, which is a non-compressible, intracavitary hemostatic agent.
CynerGene IDMP in The companyis developing, validating and implementingy a supplemental diagnosis of Malaria, HIV, and Dengue using its Infectious Diseased Multiplex Panel approach, which could allow for creationn of biosensors. LLC in Baltimore: The company is developing required components and system framework to enable conversationalo interfaces fortelemedicine tools. Such tools woul allow professional medics touse voice, gesture, and other human-- computer interactions to access and document information in electronicx medical records. in Rockville: The company is developingy technology to preserve mammalian cells in dried formay that can easilybe re-hydrated for a variety of uses.
LLC in The company is evaluating the effecg of Imagilin patented probioticsx as a food supplement to enhance the immunde responsiveness of guinea pigs upon immunizatiohn or challenge withvirulent pathogens. The evaluationm will suggest the ability of Imagilin patentec probiotics to enhance the immunizatio ofa vaccine. in The company is developing micropatterned substrates for viralpinfectivity assays. Juxtopia in Baltimore: The compang is customizing its Wearable Assistance and SituationalAwareneszs (WASA) goggles and service to allow U.S.
Army combay medics to access and document information to electrical medicaol recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapies to trear brain and spinal cord injuries.